Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
124 | 23152 | 33.8 | 77% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
138 | 61769 | HEPATITIS C VIRUS//HEPATITIS B VIRUS//HEPATITIS C |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
224 | 3815 | CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE |
229 | 3786 | HEPATITIS B VACCINE//HEPATITIS B//HEPATITIS B VACCINATION |
1581 | 2502 | INTERNAL MED MOL BIOL 2//HEPADNAVIRUS//DUCK HEPATITIS B VIRUS |
1852 | 2384 | HEPATITIS B VIRUS//PRECORE//PRECORE MUTATION |
5064 | 1612 | IGM ANTI HBC//ANTI HBC IGM//HBVDNA |
5300 | 1576 | OCCULT HBV INFECTION//ANTI HBC//OCCULT HEPATITIS B VIRUS INFECTION |
5781 | 1508 | HBX//HEPATITIS B VIRUS X PROTEIN//X PROTEIN |
6139 | 1460 | PATHOGENESE VIRUS HEPATITE B//WOODCHUCK HEPATITIS VIRUS//WOODCHUCK |
7201 | 1317 | HEPATITIS DELTA VIRUS//HEPATITIS D VIRUS//HDV RNA |
11220 | 933 | BIO NANOCAPSULE//RECOMBINANT HEPATITIS B SURFACE ANTIGEN//PRE S1 |
11434 | 916 | HEPATITIS B IMMUNOGLOBULIN//HBIG//HEPATITIS B RECURRENCE |
12238 | 857 | HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION |
21067 | 374 | REPRINT SERV//HEPATITIS VACCINATION//EDMOND DE ROTH ILD FDN |
32134 | 112 | IMMUNOLOGICAL AGENTS//INT MED PROGRAMME//CLINICAL PREDICTIONS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPATITIS B VIRUS | Author keyword | 2792 | 59% | 13% | 3107 |
2 | CHRONIC HEPATITIS B | Author keyword | 1169 | 66% | 5% | 1073 |
3 | HEPATITIS B | Author keyword | 1077 | 46% | 8% | 1745 |
4 | LAMIVUDINE | Author keyword | 882 | 63% | 4% | 888 |
5 | ENTECAVIR | Author keyword | 651 | 83% | 2% | 367 |
6 | HBV DNA | Author keyword | 616 | 81% | 2% | 371 |
7 | HBV | Author keyword | 580 | 48% | 4% | 885 |
8 | HEPATITIS B E ANTIGEN | Author keyword | 348 | 90% | 1% | 149 |
9 | HBSAG | Author keyword | 303 | 59% | 1% | 342 |
10 | HBEAG | Author keyword | 272 | 84% | 1% | 148 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATITIS B VIRUS | 2792 | 59% | 13% | 3107 | Search HEPATITIS+B+VIRUS | Search HEPATITIS+B+VIRUS |
2 | CHRONIC HEPATITIS B | 1169 | 66% | 5% | 1073 | Search CHRONIC+HEPATITIS+B | Search CHRONIC+HEPATITIS+B |
3 | HEPATITIS B | 1077 | 46% | 8% | 1745 | Search HEPATITIS+B | Search HEPATITIS+B |
4 | LAMIVUDINE | 882 | 63% | 4% | 888 | Search LAMIVUDINE | Search LAMIVUDINE |
5 | ENTECAVIR | 651 | 83% | 2% | 367 | Search ENTECAVIR | Search ENTECAVIR |
6 | HBV DNA | 616 | 81% | 2% | 371 | Search HBV+DNA | Search HBV+DNA |
7 | HBV | 580 | 48% | 4% | 885 | Search HBV | Search HBV |
8 | HEPATITIS B E ANTIGEN | 348 | 90% | 1% | 149 | Search HEPATITIS+B+E+ANTIGEN | Search HEPATITIS+B+E+ANTIGEN |
9 | HBSAG | 303 | 59% | 1% | 342 | Search HBSAG | Search HBSAG |
10 | HBEAG | 272 | 84% | 1% | 148 | Search HBEAG | Search HBEAG |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | E ANTIGEN | 2048 | 85% | 5% | 1061 |
2 | SURFACE ANTIGEN | 1770 | 51% | 11% | 2473 |
3 | ADEFOVIR DIPIVOXIL | 1230 | 79% | 3% | 785 |
4 | LAMIVUDINE THERAPY | 923 | 83% | 2% | 529 |
5 | LAMIVUDINE | 792 | 46% | 6% | 1283 |
6 | E ANTIGEN SEROCONVERSION | 779 | 92% | 1% | 315 |
7 | PRECORE REGION | 759 | 91% | 1% | 312 |
8 | HBV INFECTION | 715 | 77% | 2% | 486 |
9 | PHYLOGENETIC RELATEDNESS | 675 | 87% | 1% | 326 |
10 | HBSAG | 674 | 79% | 2% | 436 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF VIRAL HEPATITIS | 149 | 25% | 2% | 515 |
2 | JOURNAL OF MEDICAL VIROLOGY | 147 | 14% | 4% | 989 |
3 | JOURNAL OF HEPATOLOGY | 87 | 11% | 3% | 767 |
4 | HEPATITIS MONTHLY | 52 | 26% | 1% | 171 |
5 | ANTIVIRAL THERAPY | 29 | 12% | 1% | 221 |
6 | INTERVIROLOGY | 25 | 11% | 1% | 206 |
7 | HEPATOLOGY INTERNATIONAL | 22 | 20% | 0% | 101 |
8 | LIVER | 13 | 10% | 1% | 116 |
9 | DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION | 8 | 14% | 0% | 51 |
10 | PROGRESS IN LIVER DISEASES | 3 | 18% | 0% | 13 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chronic hepatitis B | 2007 | 1301 | 233 | 92% |
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update | 2008 | 440 | 98 | 99% |
Hepatitis B virus infection | 2009 | 383 | 116 | 98% |
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences | 2004 | 1023 | 62 | 95% |
HBV and the immune response | 2015 | 6 | 76 | 75% |
Medical progress - Hepatitis B virus infection | 1997 | 1525 | 81 | 79% |
Drug therapy - Hepatitis B virus infection | 2008 | 376 | 98 | 95% |
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | 2004 | 1097 | 72 | 76% |
Incidence of natural resistance mutations in naive chronic hepatitis B patients: A systematic review and meta-analysis | 2015 | 3 | 45 | 98% |
HEPATITIS-B VIRUS IMMUNOPATHOGENESIS | 1995 | 1101 | 104 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEPATITIS | 82 | 34% | 0.9% | 201 |
2 | CLIN MOL INFORMAT MED | 79 | 57% | 0.4% | 93 |
3 | HEPATOL | 76 | 12% | 2.6% | 600 |
4 | INTERNAL MED MOL BIOL 2 | 53 | 89% | 0.1% | 24 |
5 | U871 | 52 | 56% | 0.3% | 63 |
6 | RANSOME | 41 | 100% | 0.1% | 15 |
7 | PATHOGENESE VIRUS HEPATITE B | 35 | 89% | 0.1% | 16 |
8 | U271 | 33 | 41% | 0.3% | 63 |
9 | UNIT CLIN MOL HEPATOL | 28 | 81% | 0.1% | 17 |
10 | VIRAL HEPATITIS | 27 | 19% | 0.6% | 133 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015046 | HEPATITIS E VIRUS//HEPATITIS A//HEPATITIS E |
2 | 0.0000012869 | HEPATITIS C VIRUS//HEPATITIS C//HCV |
3 | 0.0000012153 | BLOOD DONATION//SE MICHIGAN REG//BLOOD DONORS |
4 | 0.0000010163 | NEEDLESTICK INJURIES//DENTAL UNIT WATERLINES//GLOVE PERFORATION |
5 | 0.0000006690 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3 |
6 | 0.0000004440 | LIVER TRANSPLANTATION//LIVING DONOR LIVER TRANSPLANTATION//HEPATIC ARTERY THROMBOSIS |
7 | 0.0000003604 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
8 | 0.0000003188 | NON ALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC STEATOHEPATITIS//TRANSIENT ELASTOGRAPHY |
9 | 0.0000002754 | HLA B8 DR3//INTERDISCIPLINARY STUDIES SECT//AH 81 |
10 | 0.0000002580 | MELOTHRIA MADERASPATANA//OSBECKIA ASPERA//PHOTOLYSIS OF H2O2 |